
Never mind the hemophilia, a soccer player can still confidently bump into others while hustling downfield thanks to the Idelvion treatment, at least according to CSL Behring promotional materials, anyway.
The drug maker used such an image — specifically, a man who is about to head or kick a soccer ball while jumping high in the air — to promote its hemophilia B medication on its product website and in patient brochures, exhibit panels, and sales aids.
Sounds promising, yes? Not to the Food and Drug Administration, though.